Effect of natural and structurally modified bile acids on cholesterol metabolizing enzymes in rat liver microsomes. II
โ Scribed by E. De Fabiani; M. Crestani; L. Fasoli; E. Bosisio
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 350 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0009-3084
No coin nor oath required. For personal study only.
โฆ Synopsis
The effect of ursodeoxycholic acid analogues bearing modifications at the side-chain moiety of the molecule was tested on cholesterol 7a-hydroxylase and HMG-CoA reductase in rat liver microsomes. The compounds included 23R,S mixture and the single isomers 23R and 23S of 23 methylursodeoxycholic acid (23-methyl UDCA), the isomeric mixture (cis + trans) of 3a,7Bdibydroxy-20,22-methylen-5B-cholan-23-oic acid (norcypro-UDCA) and the corresponding single isomers. Each steroid was added to liver microsomes as the sodium salt, at concentrations ranging from 25 to 200 ~M. Isomers 23R and 23S of 23-methyl-UDCA inhibited cholesterol 7a-hydroxylase in a concentration-dependent manner. The inhibitory capacity was similar for the two isomers. The extent of inhibition oftbe analogues was greater than that of the parent compound UDCA. Shortening of the side-chain in norcypro-UDCA resulted in a partial loss of the inhibitory effect, as compared to cypro-UDCA (3a,7B-dibydroxy-22,23-methylen-5B-cholan-24-oic acid). None of these bile acid derivatives affected the activity of the enzyme HMG-CoA reductase.
๐ SIMILAR VOLUMES
Bile acid synthesis is believed to be regulated by bile salts returning to the liver via the portal vein and suppressing cholesterol 7a-hydroxylase, the rate-limiting enzyme in the bile acid biosynthesis pathway. In order to characterize the relative effectiveness of bile salts in regulating bile ac
The effect of ursodeoxycholic acid administration on liver function tests and on bile acid metabolism was investigated in 18 patients with chronic active hepatitis. Three different doses of ursodeoxycholic acid-250 mg, 500 mg and 750 mg-were administered daily to each patient for consecutive 2-mo pe
Cytosolic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase catalyzes the formation of HMG-CoA, the substrate for the rate-controlling enzyme in the cholesterol biosynthetic pathway. To explore the regulation in liver, we developed a new, accurate, and reliable reversed-phase ion-pair chromat